article thumbnail

PO-06-028 SHORT-TERM OUTCOMES OF LEADLESS PACEMAKER IMPLANTATION IN THE UNITED STATES – INSIGHT FROM NATIONAL READMISSION DATABASE 2016-2020

HeartRhythm

Since its first Food and Drug Administration (FDA) approval in 2016, there has been a significant uptrend in the utilization of leadless pacemakers (LL-PPM).

article thumbnail

Abstract 195: Changing Trends of Thrombolysis and Thrombectomy for Low Severity Stroke: National Inpatient Sample Analysis (2016?2020)

Stroke: Vascular and Interventional Neurology

1) This study aims to examine the evolving trends of intravenous thrombolysis (IVT), endovascular thrombectomy (EVT), and their combination in low NIHSS acute ischemic stroke (AIS) management in the United States from 2016 to 2020.MethodsWe MethodsWe accessed the national inpatient sample database from 2016 through 2020.

article thumbnail

Intensive Versus Traditional Cardiac Rehabilitation: Mortality and Cardiovascular Outcomes in a 2016–2020 Retrospective Medicare Cohort

Circulation: Cardiovascular Quality & Outcomes

Qualifying events were captured from May 1, 2016 to December 31, 2019 and ICR/CR utilization captured from May 1, 2016 to December 31, 2020. Dose-response was assessed by the number of days attended.Results:From 2016 to 2019, 1 277 358 unique patients met at least one qualifying indication for ICR/CR from 2016 to 2019.

article thumbnail

PO-03-166 CHARACTERISTICS AND 5-YEAR TREND IN LEADLESS PACEMAKER IMPLANTATION IN THE UNITED STATES – INSIGHT FROM NATIONAL READMISSION DATABASE (2016-2020)

HeartRhythm

Leadless VVI pacemakers (LL-PPM), first approved by Food and Drug Administration (FDA) in 2016, emerged as an alternative for transvenous pacemakers to reduce device-related complications.

article thumbnail

Abstract TMP100: Acute Ischemic Stroke in Young Adults: A Comparative Analysis of Outcomes and Mortality in Metabolically Healthy Obese vs. Normal Weight Individuals, 2016-2019 Cohort

Stroke Journal

Methods:Data from the National Inpatient Sample (2016-2019) was analyzed to identify young MHO and MH-NW AIS patients using ICD-10 codes. From 2016 to 2019, AIS incidence rose slightly, significant only for the MH-NW cohort. The in-hospital mortality rate was significantly lower in MHO patients (6.0%

Obesity 40
article thumbnail

Abstract WP235: Cannabis Use Disorder in Elderly Stroke Survivors (?65 Years) Elevates the Risk of Stroke Recurrence: An Analysis From the National Inpatient Sample (2016-2019)

Stroke Journal

From 2016 to 2019, CUD among stroke survivors rose from 0.24% to 0.37%. Multivariable statistical methods assessed demographics, comorbidities, and temporal trends.Results:Out of 5,284,119 elderly stroke survivors, 16,820 (0.3%) had CUD and presented younger (median age: 69 vs. 79), predominantly male (68.8% vs. 28.4%).

article thumbnail

Abstract 13: Prior Bariatric Surgery is Associated With Reduced Risk of Recurrent Stroke Among Elderly Obese Stroke Survivors: A National Inpatient Sample Study (2016-2019)

Stroke Journal

Introduction:The paucity of large-scale data exploring the effect of prior bariatric surgery on recurrent stroke outcomes in elderly obese stroke survivors led us to address the gap, with an emphasis on the risk of recurrent stroke and its trends.Methods:A retrospective study was conducted using National Inpatient Sample data from 2016-2019.

Obesity 40